Search

Your search keyword '"Tsutsui H"' showing total 1,966 results

Search Constraints

Start Over You searched for: Author "Tsutsui H" Remove constraint Author: "Tsutsui H"
1,966 results on '"Tsutsui H"'

Search Results

2. Hydrodynamic characterization within a spinner flask and a rotary wall vessel for stem cell culture

3. The effects of resonant magnetic perturbations and charge-exchange reactions on fast ion confinement and neutron emission in the Mega Amp Spherical Tokamak

4. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

5. Correcting basin-scale snowfall in a mountainous basin using a distributed snowmelt model and remote-sensing data

7. Correcting basin-scale snowfall in a mountainous basin using a distributed snowmelt model and remote sensing data

8. Efficient dielectrophoretic patterning of embryonic stem cells in energy landscapes defined by hydrogel geometries

12. Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice:: GLORIA-AF Registry

14. Geographic variation in heart failure with reduced ejection fraction: insights from the VICTORIA trial

15. Empagliflozin in heart failure with a preserved ejection fraction

16. Cardiovascular and renal outcomes with empagliflozin in heart failure

17. Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial

18. Plasma physics and control studies planned in JT-60SA for ITER and DEMO operations and risk mitigation

19. Evaluation of the effect of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR‐Reduced trial

20. Plasma physics and control studies planned in JT-60SA for ITER and DEMO operations and risk mitigation

21. Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysis

22. Hippocampal Sparing Radiotherapy in adults with Primary Brain Tumors: A comparative planning and dosimetric study using IMPT, IMRT and 3DCRT

24. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

25. Completion of JT-60SA construction and contribution to ITER

26. Heart failure in younger patients: the Meta-analysis Global Group in Chronic Heart Failure (MAGGIC)

27. Evaluation of the effect of sodium–glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial

28. Evaluation of the effects of sodium–glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial

29. Cardiovascular and renal outcomes with empagliflozin in heart failure

31. The relationships among the pulse rate, use of beta-blockers, and prognosis in patients with ischemic heart disease in a real-world database using a storage system

35. Influence of neprilysin inhibition on the efficacy and safety of empagliflozin in patients with chronic heart failure and a reduced ejection fraction: The EMPEROR-Reduced trial

36. Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy

37. Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society Position Statement on Endomyocardial Biopsy

38. Empagliflozin in Heart Failure with a Preserved Ejection Fraction

39. Stabilization of vertical plasma position in the PHiX tokamak with saddle coils

40. Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry

42. 3-Dimensional stress analysis of virial-limit coils

43. Quench properties of a 7-T force-balanced helical coil for large-scale SMES

44. Evaluation of the effects of sodium–glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial

45. Evaluation of the effect of sodium–glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial

46. Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial

47. Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: An Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

48. WiFi fingerprint based indoor positioning systems using estimated reference locations

49. Burn control simulation experiments in JT-60U

Catalog

Books, media, physical & digital resources